Role of cholesterol in embryonic development

American Journal of Clinical Nutrition

Volumn 71, Issue 5 SUPPL., 2000, Pages

  Roux, Charles ^a   Wolf, Claude ^b   Mulliez, Nicole ^b   Gaoua, Wassila ^b   Cormier, Valerie ^b   Chevy, Françoise ^b   Citadelle, Danièle ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b NONE

Author keywords

7 dehydrocholesterol; AY 9944; BM 15766; Cholesterol; Holoprosencephaly; Limb anomalies; Masculinization deficiency; Rats; Smith Lemli Opitz syndrome; Sonic hedgehog; Triparanol

Indexed keywords

7 DEHYDROCHOLESTEROL; CLOMIFENE; TRIPARANOL;

CATALYSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONFERENCE PAPER; CORPUS CALLOSUM AGENESIS; DISEASE ASSOCIATION; EMBRYO; EMBRYO DEVELOPMENT; ENZYME INHIBITION; FAILURE TO THRIVE; FINGER MALFORMATION; GAS CHROMATOGRAPHY; GENETIC ANALYSIS; HOLOPROSENCEPHALY; HUMAN; HYPOCHOLESTEROLEMIA; LIMB MALFORMATION; MALE PSEUDOHERMAPHRODITISM; MASS SPECTROMETRY; MENTAL RETARDATION MALFORMATION SYNDROME; MICROCEPHALY; PROTEIN ANALYSIS; SMITH LEMLI OPITZ SYNDROME; VIRILIZATION;

ANIMALIA; ERINACEIDAE; MAMMALIA;

EID: 0034016536     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/71.5.1270s     Document Type: Conference Paper

References (41)

1. Roux C. Action tératogène du triparanol chez l'animal. (Teratogenic action of triparanol in animal.) Arch Fr Pediatr 1964;21:451-64 (in French).
2. Roux C, Aubry A. Action tératogène chez le rat d'un inhibiteur de la synthèse du cholestérol, le AY9944. (Teratogenic action of AY9944, an inhibitor of cholesterol synthesis, in rat.) C R Soc Biol 1966;160:1353-7 (in French).
3. Roux C, Aubry M, Dupuis R. Action tératogène d'un inhibiteur de la synthèse du cholestérol, le AY9944, sur différentes espèces animales. (Teratogenic action of AY9944, an inhibitor of cholesterol synthesis, in several animal species.) C R Soc Biol 1969;163:327-32 (in French).
4. Kolf M, Chevy F, Silliart B, et al. Cholesterol biosynthesis inhibited by BM15766 induces holoprosencephaly in the rat. Teratology 1997;56:188-200.
5. Smith DW, Lemli L, Opitz JM. A newly recognized syndrome of multiple congenital anomalies. J Pediatr 1964;64:210-7.
6. Tint GS. Cholesterol defect in Smith-Lemli-Opitz syndrome. Am J Obstet Gynecol 1993;47:473-4 (letter).
7. Porter JA, Young KE, Beachy PA. Cholesterol modification of hedgehog signaling proteins in animal development. Science 1996;274:255-9.
8. Dehart DB, Lanoue L, Tint GS, Sulik KK. Pathogenesis of malformations in a rodent model for Smith-Lemli-Opitz syndrome. Am J Med Genet 1997;68:328-37.
9. 7-reductase by novel 6-aza-B-homosteroids and other analogs of a presumptive carbocationic intermediate of the reduction reaction. Biochemistry 1996;35:7069-76.
10. Roux C, Dupuis R, Horvath C, Talbot JN. Teratogenic effect of an inhibitor of cholesterol synthesis (AY9944) in rats: correlation with maternal cholesterolemia. J Nutr 1980;110:2310-2.
11. Barbu V, Roux C, Dupuis R, Gardette J, Maziere JC. Teratogenic effect of AY9944 in rats: importance of day of administration and maternal cholesterolemia. Proc Soc Exp Biol Med 1984;176:54-9.
12. Roux C, Horvath C, Dupuis R. Teratogenic action and embryolethality of AY9944: prevention by a hypercholesterolemia-provoking diet. Teratology 1979;19:35-8.
13. Gaoua W, Haddadi K, Wolf C, et al. Respective role of cholesterol shortage and precursor accumulation in the teratogenic effects of distal inhibition of cholesterol synthesis. 25th Conference of the European Teratology Society. Cannes, 14-17 September 1997. Teratology 1997;56:398 (abstr P51).
14. Haddadi K, Gaoua W, Wolf C, et al. An animal model of Smith-Lemli-Opitz syndrome disorders of masculinization. 25th Conference of the European Teratology Society, Cannes, 14-17 September 1997. Teratology 1997;56:398 (abstr P49).
15. Repetto M, Citadelle D, Dupuis R, et al. Teratogenic effect of the cholesterol synthesis inhibitor AY9944 on rat embryos in vitro. Teratology 1990;42:611-8.
16. Llirbat B, Wolf C, Chevy F, Citadelle D, Bereziat G, Roux C. Normal and inhibited cholesterol synthesis in the cultured rat embryo. J Lipid Res 1997;38:22-34.
17. Llirbat B. Néosynthèse et apport exogène de cholestérol chez l'embryon de rat en culture: effets d'un inhibiteur distal de la biosynthèse de cholestérol, l'AY9944, modèle du syndrome de Smith-Lemli-Opitz. (Neosynthesis and cholesterol intake in rat embryo in culture: effects of a distal inhibitor of cholesterol synthesis, AY9944, a model of Smith-Lemli-Opitz syndrome.) Thesis of medicine. Université Paris VI, 1997.
18. Pratt HPM. Preimplantation mouse embryos synthesize membrane sterols. Dev Biol 1982;89:101-10.
19. Gaoua W, Wolf C, Chevy F, et al. Toxicity of cholesterol precursor and oxidized by-products accumulated in Smith-Lemli-Opitz syndrome. 25th Conference of the European Teratology Society, Cannes, 14-17 September 1997. Teratology 1997;56:398 (abstr P50).
20. Maziere JC, Maziere C, Mora I. et al. Effects of AY9944 on low density lipoprotein metabolism in cultured human fibroblasts. Chem Biophys Res Commun 1984;122:955-9.
21. Kelley RI, Roessler E, Hennekam RCM, et al. Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the function of sonic hedgehog? Am J Med Genet 1996;66:478-84.
22. Le Merrer M, Briard ML, Girard S, Mulliez N, Moraine C, Imbert MC. Lethal acrodysgenital dwarfism: a severe lethal condition resembling Smith-Lemli-Opitz syndrome. J Med Genet 1988;25:88-95.
23. Lanouc L, Dehart DB, Hinsdale ME, Maeda N, Tint GS, Sulik KK. Limb, genital, CNS and facial malformations result from gene/environment-induced cholesterol deficiency: further evidence for a link to sonic hedgehog. Am J Med Genet 1997;73:24-31.
24. Farese RV, Cases S, Ruland SL, et al. A novel function for apolipoprotein B: lipoprotein synthesis in the yolk sac is critical for maternal-fetal lipid transport in mice. J Lipid Res 1996;37:347-60.
25. Tint GS, Irons M, Elias ER, et al. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 1994;330:107-13.
26. Cormier-Daire V, Wolf C, Le Merrer M, et al. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz and the lethal acrodysgenital syndromes. Eur J Pediatr 1996;155:656-9.
27. Eliaser, Irons M, Hurley AD, Tint GS, Salen G. Clinical effect of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS). Am J Med Genet 1997;68:305-10.
28. Irons M, Elias ER, Abuelo D, et al. Treatment of Smith-Lemli-Opitz syndrome: results of a multicenter trial. Am J Med Genet 1997; 68:311-4.
29. Moebius FF, Fitzky BU, Lee JN, Paik YK, Glossmann H. Molecular cloning and expression of the human Δ7-sterol reductase. Proc Natl Acad Sci USA 1998;95:1899-902.
30. Marti E, Takada R, Bumcrot DA, Sasaki H, Mc Mahon AP. Distribution of sonic hedgehog peptides in the developing chick and mouse embryo. Development 1995;121:2537-47.
31. Chiang C, Litingtung Y, Lee E, et al. Cyclopia and defective axial patterning in mice lacking sonic hedgehog gene function. Nature 1996;383:407-13.
32. Roessler H, Belloni E, Gaudenz K, et al. Mutations in the human sonic hedgehog gene cause holoprosencephaly. Nat Genet 1996;14:357-60.
33. Kolf M, Clotman F, Roux C, Picard J. Expression domains of five developmental genes in early fore-and midbrain after inhibition of cholesterol biosynthesis in rat embryos. 25th Conference of the European Teratology Society,. Cannes, 14-17 September 1997. Teratology 1997;56:393 (abstr P29).
34. Stone DM, Hynes M, Ardmanini M, et al. The tumor suppressor gene patched encodes candidate receptor for sonic hedgehog. Nature 1996;384:129-34.
35. Tabin CJ, Mc Mahon AP. Recent advances in hedgehog signalling. Trends Cell Biol 1997;7:442-6.
36. Brown DA, London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 1998;14:111-36.
37. Rujanavech C, Silberet DF. LM cell growth and membrane lipid adaptation to sterol structure. J Biol Chem 1986;261:7196-203.
38. Honda M, Tint GS, Honda A, Nguyen LB, Chen TS, Shefer S. 7-Dehydrocholesterol down-regulates cholesterol biosynthesis in cultured Smith-Lemli-Opitz syndrome skin fibroblasts. J Lipid Res 1998;39:647-57.
39. Fitzpatrick DR, Keeling JW, Evans MJ, et al. Clinical phenotype of desmosterolosis. Am J Med Genet 1998;75:145-52.
40. Willnow TE, Hilpert J, Armstrong SA, et al. Defective forebrain development in mice lacking gp330/megalin. Proc Natl Acad Sci U S A 1996;93:8460-4.
41. Cooper MK, Porter JA, Young KE, Beachy PA. Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 1998;280:1603-7.